tradingkey.logo

Core Laboratories Inc <CLB.N> expected to post earnings of 15 cents a share - Earnings Preview

ReutersApr 21, 2025 8:12 PM
  • Core Laboratories Inc CLB.N, CLB is expected to show a fall in quarterly revenue when it reports results on April 23 for the period ending March 31 2025

  • The Houston Texas-based company is expected to report a 3.8% decrease in revenue to $124.761 million from $129.64 million a year ago, according to the mean estimate from 4 analysts, based on LSEG data.The company's guidance on January 29 2025, for the period ended March 31, was for revenue between $121.00 million and $127.00 million.

  • ​LSEG's mean analyst estimate for Core Laboratories Inc is for earnings of 15 cents per share. The company's EPS guidance on January 29 2025, for the period ended March 31, was between $0.12 and $0.16

  • The current average analyst rating on the shares is "hold" and the breakdown of recommendations is 1 "strong buy" or "buy," 3 "hold" and 1 "sell" or "strong sell."

  • The mean earnings estimate of analysts was unchanged in the last three months. ​

  • Wall Street's median 12-month price target for Core Laboratories Inc is $16.00​, above​ its last closing price of $12.62. ​​​

The company's guidance on January 29 2025 for the period ended March 31 was for Earnings before Interest and Taxes between USD10.2 million and USD12.8 million.

Previous quarterly performance (using preferred earnings measure in US dollars). ​

QUARTER ENDING

STARMINESMARTESTIMATE®

LSEG IBES ESTIMATE

ACTUAL

BEAT, MET, MISSED

SURPRISE %

Dec. 31 2024

0.22

0.22

0.22

Met

0.7

Sep. 30 2024

0.23

0.23

0.25

Beat

8.2

Jun. 30 2024

0.21

0.21

0.22

Beat

6.6​

Mar. 31 2024

0.16

0.16

0.19

Beat

21.7

​​Dec. 31 2023

0.19

0.19

0.19

Met

-1.3

Sep. 30 2023

0.22

0.22

0.22

Met

-0.1​

Jun. 30 2023

0.20

0.20

0.21

Beat

5.3

Mar. 31 2023

0.16

0.16

0.19

Beat

20.3

This summary was machine generated April 21 at 20:12 GMT. All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)

Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.

Related Articles

KeyAI